Black Diamond Therapeutics
BDTX
BDTX
86 hedge funds and large institutions have $64.1M invested in Black Diamond Therapeutics in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
-8
Holders Change %
-8.51%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
22
Reduced
26
Closed
19
Calls
$3K
Puts
$192K
Net Calls
-$189K
Net Calls Change
-$16K
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$1.45M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$937K |
| 3 |
Morgan Stanley
New York
|
-$777K |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$471K |
| 5 |
Renaissance Technologies
New York
|
-$335K |
